Novo Nordisk
NVO
#21
Rank
โ‚น40.136 T
Marketcap
โ‚น9,022
Share price
-0.14%
Change (1 day)
7.60%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2024 : โ‚น1.523 Trillion

According to Novo Nordisk's latest financial reports the company has โ‚น1.523 Trillion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$โ‚น1.313 T32.06%
2022-12-31$โ‚น994.86 B24.1%
2021-12-31$โ‚น801.69 B4.72%
2020-12-31$โ‚น765.53 B24.32%
2019-12-31$โ‚น615.78 B10.88%
2018-12-31$โ‚น555.34 B8.3%
2017-12-31$โ‚น512.77 B17.73%
2016-12-31$โ‚น435.56 B-4.78%
2015-12-31$โ‚น457.42 B9.67%
2014-12-31$โ‚น417.10 B-14.34%
2013-12-31$โ‚น486.91 B23.43%
2012-12-31$โ‚น394.48 B14.31%
2011-12-31$โ‚น345.10 B16.74%
2010-12-31$โ‚น295.61 B-7.45%
2009-12-31$โ‚น319.40 B7.05%
2008-12-31$โ‚น298.37 B20.56%
2007-12-31$โ‚น247.48 B4.6%
2006-12-31$โ‚น236.61 B20.35%
2005-12-31$โ‚น196.59 B-6.56%
2004-12-31$โ‚น210.40 B8.02%
2003-12-31$โ‚น194.78 B23.38%
2002-12-31$โ‚น157.86 B13.31%
2001-12-31$โ‚น139.32 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚น7.810 T 412.66%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.208 T-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.451 T-4.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.603 T 333.42%๐Ÿ‡ซ๐Ÿ‡ท France